Ritholtz Wealth Management Amgen Inc Transaction History

Ritholtz Wealth Management

$3.28 Billion
Q3 2024

A detailed history of Ritholtz Wealth Management transactions in Amgen Inc stock. As of the latest transaction made, Ritholtz Wealth Management holds 12,365 shares of AMGN stock, worth $3.26 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

12,365

Previous 12,277 0.72%

Holding current value

$3.26 Million

Previous $3.84 Million 3.89%

% of portfolio

0.12%

Previous 0.13%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	BUY	$309.38 - $337.38 $27,225 - $29,689	88 Added 0.72%	12,365 $3.98 Million
Q2 2024 Jul 31, 2024	BUY	$262.75 - $319.31 $6,568 - $7,982	25 Added 0.2%	12,277 $3.84 Million
Q1 2024 Apr 24, 2024	BUY	$268.87 - $324.56 $29,306 - $35,377	109 Added 0.9%	12,252 $3.48 Million
Q4 2023 Jan 18, 2024	SELL	$255.7 - $288.46 $466,908 - $526,727	-1,826 Reduced 13.07%	12,143 $3.5 Million
Q3 2023 Oct 13, 2023	BUY	$218.65 - $271.46 $315,949 - $392,259	1,445 Added 11.54%	13,969 $3.75 Million
Q2 2023 Jul 14, 2023	SELL	$214.27 - $253.37 $2.68 Million - $3.17 Million	-12,509 Reduced 49.97%	12,524 $2.78 Million
Q1 2023 Apr 19, 2023	SELL	$225.79 - $275.2 $115,378 - $140,627	-511 Reduced 2.0%	25,033 $6.05 Million
Q4 2022 Jan 18, 2023	BUY	$229.03 - $291.01 $2.06 Million - $2.62 Million	8,987 Added 54.28%	25,544 $0
Q3 2022 Oct 18, 2022	BUY	$224.46 - $253.15 $828,481 - $934,376	3,691 Added 28.69%	16,557 $3.73 Million
Q2 2022 Jul 15, 2022	BUY	$230.71 - $256.74 $307,767 - $342,491	1,334 Added 11.57%	12,866 $3.13 Million
Q1 2022 Apr 14, 2022	BUY	$219.27 - $242.57 $765,252 - $846,569	3,490 Added 43.4%	11,532 $2.79 Million
Q4 2021 Jan 18, 2022	BUY	$198.88 - $227.6 $448,673 - $513,465	2,256 Added 38.99%	8,042 $1.81 Million
Q3 2021 Oct 14, 2021	SELL	$212.27 - $248.7 $41,392 - $48,496	-195 Reduced 3.26%	5,786 $1.23 Million
Q2 2021 Jul 20, 2021	BUY	$233.58 - $259.14 $99,037 - $109,875	424 Added 7.63%	5,981 $1.46 Million
Q1 2021 May 12, 2021	BUY	$221.91 - $258.6 $237,443 - $276,702	1,070 Added 23.85%	5,557 $1.38 Million
Q4 2020 Jan 19, 2021	SELL	$216.38 - $257.67 $149,085 - $177,534	-689 Reduced 13.31%	4,487 $1.03 Million
Q3 2020 Oct 23, 2020	BUY	$234.65 - $260.95 $105,592 - $117,427	450 Added 9.52%	5,176 $1.32 Million
Q2 2020 Jul 15, 2020	BUY	$197.81 - $242.74 $91,783 - $112,631	464 Added 10.89%	4,726 $1.12 Million
Q1 2020 Apr 09, 2020	BUY	$182.24 - $241.7 $87,110 - $115,532	478 Added 12.63%	4,262 $864,000
Q4 2019 Jan 17, 2020	BUY	$189.21 - $243.2 $16,272 - $20,915	86 Added 2.33%	3,784 $912,000
Q3 2019 Oct 17, 2019	BUY	$174.11 - $208.62 $6,093 - $7,301	35 Added 0.96%	3,698 $716,000
Q2 2019 Jul 15, 2019	SELL	$166.7 - $195.41 $3,667 - $4,299	-22 Reduced 0.6%	3,663 $675,000
Q1 2019 Apr 12, 2019	BUY	$180.87 - $203.88 $11,394 - $12,844	63 Added 1.74%	3,685 $700,000
Q4 2018 Jan 18, 2019	BUY	$178.4 - $208.25 $29,257 - $34,153	164 Added 4.74%	3,622 $705,000
Q3 2018 Oct 12, 2018	BUY	$185.29 - $208.89 $640,732 - $722,341	3,458 New	3,458 $717,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ritholtz Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Ritholtz Wealth Management with notifications on news.

Account

Ritholtz Wealth Management Amgen Inc Transaction History